Skip to main content

Table 3 Frequency and duration of relapses

From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

 

Relapse requiring hospitalisation, weighted average (min, max)

Relapse not requiring hospitalisation, weighted average (min, max)

Frequency (mean)

 

1.20

   Lead to early discontinuation

 

1.20 (1, 2)

   Lead to later discontinuation

1.20 (0, 2)

1.20 (1, 2)

Duration (mean, days)

80.00

66.90

   Lead to early discontinuation

100.00 (80, 120)

90.00 (80, 110)

   Lead to later discontinuation

60.00 (40, 80)

44.00 (34, 66)